PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 28, 2026Cancer Discovery0 citations

Reversing Immune Aging to Improve Immunotherapy Outcomes

View Full Paper

Key Points

  • The aim is to investigate methods to reverse immune aging and improve the effectiveness of cancer immunotherapy in older patients.
  • Exploration of mRNA-based immune rejuvenation
  • Evaluation of senolytics as potential treatments
  • Conducting human trials to test interventions
  • Age-related immune decline limits effectiveness of immunotherapy in older adults
  • Targeting immune aging shows promise in improving treatment response
  • Further research needed to address safety and complexity of human immune aging

Abstract

Age-related immune decline may limit cancer immunotherapy effectiveness, particularly in patients ages 75 and older. Researchers are exploring mRNA-based immune rejuvenation and senolytics as potential solutions, with a growing number of human trials now testing whether targeting immune aging can improve treatment response. Translating these findings more broadly will require addressing safety concerns and the complexity of human immune aging.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

A 2026 study studied this question.

synapsesocial.com/papers/69a286950a974eb0d3c019fbhttps://doi.org/10.1158/2159-8290.cd-nw2026-0018
Ask AI
Helpful
Bookmark
Share
View Full Paper